Table 3.
Multivariate analysis of factors associated with DFS and OS
| Variable |
DFS |
OS |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
| non-IM use post-HCT |
4.8 |
2.2-10.8 |
.000 |
6.2 |
2.6-15.0 |
.000 |
| > CR1 pre-HCT |
|
|
|
2.7 |
1.1-6.6 |
.023 |
| BCR-ABL(+) pre-HCT | 3.7 | 1.3-10.5 | 0.014 | |||
IM, imatinib; HR, hazard ratio; CI, confidence interval.